Biznews4d
🔒 Novo’s insulin pen phase-out sparks CompCom probe as diabetes remains a silent killer among SA women
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...
Moneyweb4d
Novo Nordisk, Sanofi face SA insulin antitrust probe
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...
Pharmaceutical Technology on MSN5d
Callio raises $187m for proof-of-concept for dual-payload ADC
Callio Therapeutics has raised $187m in a Series A financing round to achieve clinical proof-of-concept for its human ...
Newly launched Seattle cancer therapy startup Callio Therapeutics raises $187M
Biotech-focused investment firm Frazier Life Sciences launched Callio Therapeutics, a cancer treatment startup with ...
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird BioscienceFinancing ...